Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma IPOs Gain Momentum As Three More Launch In The US

May 10 2017

• By Mandy Jackson

stock

Related Content

US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Dec 31 2016

VC Roundup: Caribou Completes $30m Non-IPO CRISPR Financing; $205m In Cash For Five Others

May 16 2016

IPO Update: Values Slip As Four More Biopharma Firms Go Public In October

Nov 07 2016

Best-In-Class Or First-In-Class: CGRP Inhibitors Line Up To Win The Migraine Market

May 09 2017

After Tocagen Thaws IPO Freeze, Verona And Zymeworks Bring April Total To Three

Apr 29 2017

Deal Watch: AbbVie, arGEN-X To Explore Immuno-Oncology According To GARP

May 02 2016

Related Companies

Ovid Therapeutics, Inc.

UroGen Pharma, Ltd.

Biohaven Pharmaceutical Holding Company Ltd.

Verona Pharma plc

Zymeworks, Inc.

argenx N.V.

G1 Therapeutics Inc.

AbbVie Inc.

Accelerated Pharma, Inc.

AnaptysBio, Inc.

Jounce Therapeutics, Inc.

ObsEva SA

BeyondSpring Inc.

Tocagen, Inc.

Additional Topics

Financing Business Strategies StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window